HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stacy L Moulder Selected Research

Paclitaxel (Taxol)

11/2021Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
10/2021Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
2/2010A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stacy L Moulder Research Topics

Disease

42Neoplasms (Cancer)
03/2024 - 06/2002
41Breast Neoplasms (Breast Cancer)
04/2024 - 06/2002
25Triple Negative Breast Neoplasms
04/2024 - 11/2010
12Pathologic Complete Response
12/2022 - 01/2016
6Neoplasm Metastasis (Metastasis)
01/2020 - 07/2011
4Disease Progression
04/2024 - 02/2010
3Residual Neoplasm
05/2022 - 07/2016
3Ovarian Neoplasms (Ovarian Cancer)
05/2014 - 03/2011
2Inflammatory Breast Neoplasms
04/2024 - 08/2013
2Overweight
01/2019 - 01/2013
2Insulin Resistance
01/2019 - 01/2013
2Diarrhea
07/2017 - 10/2008
2Circulating Neoplastic Cells
07/2014 - 08/2013
2Colorectal Neoplasms (Colorectal Cancer)
03/2014 - 03/2011
1Hyperglycemia
10/2021
1Carcinosarcoma
10/2021
1Necrosis
01/2021
1Neoplasm Micrometastasis
09/2020
1Brain Neoplasms (Brain Tumor)
01/2020
1Hyperinsulinism (Hyperinsulinemia)
01/2019
1Anemia
07/2017
1Exanthema (Rash)
07/2017
1Hypokalemia
07/2017

Drug/Important Bio-Agent (IBA)

13Hormones (Hormone)IBA
10/2021 - 01/2013
11Trastuzumab (Herceptin)FDA Link
11/2021 - 06/2002
9Biomarkers (Surrogate Marker)IBA
04/2024 - 07/2016
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 12/2008
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2019
4Metformin (Glucophage)FDA LinkGeneric
10/2021 - 01/2013
4Proteins (Proteins, Gene)FDA Link
10/2021 - 06/2002
4ErbB Receptors (EGF Receptor)IBA
10/2020 - 10/2008
4Estrogen ReceptorsIBA
10/2020 - 11/2010
4Lapatinib (GW572016)FDA Link
07/2019 - 09/2010
4Bevacizumab (Avastin)FDA Link
04/2017 - 09/2010
4human ERBB2 proteinIBA
01/2017 - 07/2014
3B7-H1 AntigenIBA
04/2024 - 01/2021
3AnthracyclinesIBA
06/2023 - 06/2008
3talazoparibIBA
05/2022 - 01/2020
3Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2022 - 05/2018
3pertuzumabIBA
11/2021 - 12/2018
3Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 02/2010
3Progesterone Receptors (Progesterone Receptor)IBA
10/2020 - 11/2010
3Letrozole (Femara)FDA LinkGeneric
07/2019 - 12/2017
3Estrogens (Estrogen)FDA Link
01/2019 - 05/2014
3EverolimusFDA Link
01/2019 - 05/2014
3MTOR InhibitorsIBA
01/2016 - 03/2012
3Tyrosine Kinase InhibitorsIBA
07/2015 - 06/2002
2Phenobarbital (Luminal)FDA Link
03/2024 - 05/2019
2N-acetyltalosaminuronic acid (NAT)IBA
03/2024 - 10/2021
2Androgen Receptors (Androgen Receptor)IBA
03/2024 - 05/2019
2130-nm albumin-bound paclitaxelIBA
06/2023 - 07/2011
2Ado-Trastuzumab EmtansineIBA
11/2021 - 07/2019
2Capecitabine (Xeloda)FDA Link
07/2019 - 06/2008
2Histone Deacetylase InhibitorsIBA
01/2019 - 03/2014
2exemestane (Aromasin)FDA Link
01/2019 - 01/2013
2Epidermal Growth Factor (EGF)IBA
01/2019 - 12/2018
2taxaneIBA
01/2018 - 06/2008
2GemcitabineFDA Link
01/2018 - 08/2013
2DNA (Deoxyribonucleic Acid)IBA
07/2015 - 03/2011
2Anastrozole (Arimidex)FDA LinkGeneric
05/2015 - 05/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014 - 03/2014
2Monoclonal AntibodiesIBA
03/2014 - 06/2002
2Taxoids (Taxanes)IBA
12/2008 - 06/2008
2Gefitinib (Iressa)FDA Link
10/2008 - 06/2003
1pembrolizumabIBA
04/2024
1atezolizumabIBA
06/2023
1Complement System Proteins (Complement)IBA
01/2022
1ganitumabIBA
10/2021
1Hemoglobins (Hemoglobin)IBA
10/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2021
1Histones (Histone)IBA
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1mirvetuximab soravtansineIBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1Folate Receptor 1IBA
01/2021
1AlpelisibIBA
01/2020
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2020
1olaparibIBA
01/2020
1thiamine triphosphorate (TTP)IBA
07/2019
1telomerase RNA (bTR)IBA
07/2019
1ProteomeIBA
01/2019
1TOR Serine-Threonine KinasesIBA
01/2019
1entinostat (MS 275)IBA
01/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019
1Imatinib Mesylate (Gleevec)FDA Link
12/2018
1tipifarnib (R115777)IBA
01/2018
1VimentinIBA
01/2018
1Aromatase InhibitorsIBA
12/2017
1Cyclin EIBA
12/2017
1Cytostatic AgentsIBA
12/2017
1tucatinibIBA
07/2017
1Transaminases (Aminotransferases)IBA
07/2017

Therapy/Procedure

29Therapeutics
04/2024 - 11/2004
19Neoadjuvant Therapy
03/2024 - 01/2016
13Drug Therapy (Chemotherapy)
04/2024 - 05/2007
3Aftercare (After-Treatment)
01/2019 - 12/2015
1Induction Chemotherapy
04/2024
1Immunotherapy
04/2024
1Surgical Instruments (Clip)
01/2022
1Lymph Node Excision (Lymph Node Dissection)
09/2020